X

WHY BLOOM BURTON & CO?
SERVICES
TRANSACTIONS
TEAM
EVENTS
News & Insights
CAREERS
CONTACT

•

M

E

N

U

•

March 31, 2016

Bloom Burton’s analyst David Martin speaks to BNN about Concordia's latest earnings

Click on the image to view the full video.

RELATED NEWS

Roberto Bellini Receives the 2024 Bloom Burton Award The Globe and Mail | Ex-Chinook team launches Borealis Biosciences with $150-million from Novartis, Versant Hamilton City Magazine | Coming to life at McMaster University Acquisition of Fusion Pharmaceuticals Completed Three Finalists Announced for the 2024 Bloom Burton Award The Globe and Mail | LSD, Ecstasy, magic mushrooms coming to a clinic near you? Legalization nears for psychedelics Apotex to Acquire Searchlight Pharma, a Canadian Specialty Branded Pharmaceutical Leader Cybin Announces Closing of the Oversubscribed Private Placement of U.S. $150 Million The Globe and Mail | AstraZeneca buys Hamilton-based smart cancer drug maker Fusion Pharmaceuticals for $2-billion The Globe and Mail | Vancouver readies for its position as a global pharma capital as B.C.’s biotech boom takes off

2024 BLOOM BURTON & CO DESIGNED & DEVELOPED BY THE TEAM AT PIXELCARVE MEMBER CIRO MEMBER CIPF PRIVACY POLICY COMPLAINT BEST EXECUTION POLICY ACCESSIBILITY POLICY BUSINESS CONTINUITY PLAN LEGAL DISCLAIMER CONFLICTS OF INTEREST